search
Back to results

Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)

Primary Purpose

Brain Injuries, Traumatic

Status
Terminated
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
7.5% Hypertonic Saline in 6% Dextran-70 (HSD)
7.5% Hypertonic Saline (HS)
0.9% Normal Saline (NS)
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Brain Injuries, Traumatic focused on measuring Traumatic, Brain injury

Eligibility Criteria

15 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Blunt trauma Pre-hospital Glasgow Coma Scale equal to or less than 8(GCS≤8)* Age 15 years or older or 50 kg or more Patients who met the inclusion criteria above and did not meet the exclusion criteria below but who had systolic blood pressure (SBP) ≤70 or SBP>70 and SBP≤90 and heart rate (HR)≥108 were included in the Hypertonic Resuscitation following Traumatic Injury study that focused on shock patients who may or may not have a traumatic brain injury (TBI). In other words, patients with both TBI and shock would not be included in this study of TBI patients without shock at the time of enrollment. Exclusion Criteria: Known or suspected pregnancy Age younger than 15 years or less than 50 kg if age unknown Ongoing pre-hospital cardiopulmonary resuscitation (CPR) Administration of more than 2L crystalloid or any colloid or blood products Severe hypothermia (T less than 28C) Drowning or asphyxia due to hanging Burns TBSA more than 20% Isolated penetrating injury to the head Inability to obtain pre-hospital intravenous access Time of call received at dispatch to study intervention more than four hours Known prisoners

Sites / Locations

  • Alabama Resuscitation Center, University of Alabama
  • Orange County/UC Irvine
  • UCSD-San Diego Resuscitation Research Center
  • Iowa Resuscitation Network, University of Iowa Carver College of Medicine
  • Portland Resuscitation Outcomes Consortium, Oregon Health & Sciences University
  • The Pittsburgh Resuscitation Network, University of Pittsburgh
  • The Regional Medical Center at Memphis
  • Dallas Center for Resuscitation Research, University of Texas Southwestern Medical Center
  • Seattle-King County Center for Resuscitation Research, University of Washington
  • Milwaukee Resuscitation Network, Medical College of Wisconsin
  • University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute
  • Toronto Regional Resuscitation Research Out-of-Hospital Network, University of Toronto

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Placebo Comparator

Arm Label

7.5% hypertonic saline/6% dextran (HSD)

7.5% hypertonic saline (HS)

0.9% normal saline (NS)

Arm Description

250 ml intravenous bolus administration of 7.5% saline/6% dextran 70

250 ml intravenous bolus administration of 7.5% hypertonic saline

250 ml intravenous bolus administration of 0.9% saline

Outcomes

Primary Outcome Measures

Glasgow Outcome Scale-Extended (GOSE)≤4 at 6 Months: Completer Analysis
Glasgow outcome score extended (GOSE) contains eight categories: 1. Dead, 2. Vegetative State (VS), 3. Lower Severe Disability (Lower SD), 4. Upper Severe Disability (Upper SD), 5. Lower Moderate Disability (Lower MD), 6. Upper Moderate Disability (Upper MD), 7. Lower Good Recovery (Lower GR) and 8. Upper Good Recovery (Upper GR). A measured neurological outcome of GOSE≤4 is a poor outcome of severe disability, vegetative state, or death. Completer analysis includes only those patients with GOSE completed at 6 months after injury.
Glasgow Outcome Scale-Extended (GOSE)≤4 at 6 Months: Imputed Analysis
Glasgow outcome score extended (GOSE) contains 8 categories: 1. Dead, 2. Vegetative State, 3. Lower Severe Disability, 4. Upper Severe Disability, 5. Lower Moderate Disability, 6. Upper Moderate Disability, 7. Lower Good Recovery and 8. Upper Good Recovery. To adjust for 15% of subjects with absent 6-month GOSE data, an analysis using 20 hot deck imputations for the 6-month GOSE was done using data from patients who were discharged alive based on 1-month post discharge GOSE data or discharge GOSE (if 1-month post discharge data were not available), length of hospital stay, and treatment group.

Secondary Outcome Measures

Subgroup of Participants With Head Abbreviated Injury Scores (AIS) Greater Than or Equal to 4 (Head AIS≥4) Assessed to Have Glasgow Outcome Scale-Extended (GOSE)≤4 at 6 Months: Imputed Analysis
The Abbreviated Injury Scale (AIS) ranks injuries on a scale of 1 to 6, with 1 being minor, 2 moderate, 3 serious, 4 severe, 5 critical and 6 an unsurvivable injury. A priori secondary analyses included the subgroup of participants in each intervention group with a head AIS≥4, which is a diagnostic indicator of severe to lethal head injury. Of this subset of participants with AIS≥4, a second subset of participants with a GOSE≤4 at the 6 month follow up was analyzed. GOSE≤4 represents Upper Severe Disability or worse outcomes. 15% of subjects required imputation analysis for 6-month GOSE.
Subgroup of Participants With Head Abbreviated Injury Scores (AIS) Greater Than or Equal to 2 (Head AIS≥2) Assessed to Have Glasgow Outcome Scale-Extended (GOSE)≤4 at 6 Months: Imputed Analysis
The Abbreviated Injury Scale (AIS) ranks injuries on a scale of 1 to 6, with 1 being minor, 2 moderate, 3 serious, 4 severe, 5 critical and 6 an unsurvivable injury. A priori secondary analyses included the subgroup of participants in each intervention group with a head AIS≥2, which is a diagnostic indicator of moderate to lethal head injury. Of this subset of participants with AIS≥2, a second subset of participants with a GOSE≤4 at the 6 month follow up was analyzed. GOSE≤4 represents Upper Severe Disability or worse outcomes. 15% of subjects required imputation analysis for 6-month GOSE.
Disability Rating Score (DRS) Categories of Disability
The DRS is an additional measure of neurological outcome that categorizes the patient's level of disability on a scale of 0 to 29, with 0 indicating no disability to 29 indicating extreme vegetative state. To adjust for 15% of subjects with absent 6-month DRS data, an analysis using 20 hot deck imputations for the 6-month DRS was done using data from patients who were discharged alive based on 1-month post discharge DRS data or discharge DRS (if 1-month post discharge data were not available), length of hospital stay, and treatment group.
28 Day Survival
The patient who is admitted to the hospital after injury and is alive on the 28th day after injury. For 28-day survival, patients with missing 28-day vital status who were known to be discharged alive prior to 28 days were assumed to be alive at day 28.
Survival at Hospital Discharge up to 6 Months From Date of Injury
The patient who is admitted to the hospital alive after injury and is alive when discharged from the hospital up to 6 months from the date of injury.
Acute Respiratory Distress Syndrome (ARDS)-Free Survival to Day 28
The patient is alive and free of ARDS from the date of injury through to the 28th day following injury. The diagnosis of ARDS is based on standard criteria: a) hypoxia with a ratio of arterial oxygen pressure to percent oxygen delivered of less than 200; b) bilateral infiltrates on chest X-ray; and c) clinical evidence of increased left atrial pressure or pulmonary artery wedge pressure of greater than 18 mmHg.
Worst Multiple Organ Dysfunction Score (MODS) Through Day 28
Multiple Organ Dysfunction Score is described as: Six organ systems were chosen: 1) respiratory; 2) renal; 3) hepatic; 4) cardiovascular; 5) hematologic; and 6) neurologica. A score of 0-4 was allotted for each organ according to function (0 being normal function through 4 for most severe dysfunction) with a maximum score of 24. The worst score based on available data (missing values were assumed normal) was taken for calculation of the aggregate score. Deaths are assigned the worst score (24).
Ventilator-free Days Through Day 28
The number of days beginning with the day of 911 call counted as "Day 0" through day 28 that the patient did not require mechanical ventilation. Deaths are assigned the worst score (0).
Days Alive Out of the Intensive Care Unit (ICU) Through Day 28
The number of days the patient is alive and not being cared for in the intensive care unit
Days Alive Out of the Hospital Through Day 28
The number of days the patient is alive and no longer an inpatient in the hospital through day 28
Presence of Nosocomial Infections
Includes one or more nosocomial infections diagnosed during the hospital stay but not present on admission to the hospital from the following list: pneumonia, bloodstream infection, urinary tract infection, and/or wound infection
Total Fluids in First 24 Hours
The average (mean) total amount of intravenous (IV) fluids given in the pre-hospital setting and the hospital setting in the first 24 hours following the time of the 911 call
Packed Red Blood Cells (PRBC) First 24 Hours
The average (mean) number of units of packed red blood cells (PRBC) transfused in the first 24 hours following the time of the 911 call in each group.
Discharge Disposition
Disposition of patient at the time of discharge from the acute care hospital

Full Information

First Posted
April 17, 2006
Last Updated
May 16, 2011
Sponsor
University of Washington
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), National Institute of Neurological Disorders and Stroke (NINDS), U.S. Army Medical Research and Development Command, Canadian Institutes of Health Research (CIHR), Canadian Department of National Defense, Heart and Stroke Foundation of Canada
search

1. Study Identification

Unique Protocol Identification Number
NCT00316004
Brief Title
Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)
Official Title
Phase 3 Study of Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)
Study Type
Interventional

2. Study Status

Record Verification Date
May 2011
Overall Recruitment Status
Terminated
Why Stopped
Futility
Study Start Date
May 2006 (undefined)
Primary Completion Date
May 2009 (Actual)
Study Completion Date
January 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University of Washington
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), National Institute of Neurological Disorders and Stroke (NINDS), U.S. Army Medical Research and Development Command, Canadian Institutes of Health Research (CIHR), Canadian Department of National Defense, Heart and Stroke Foundation of Canada

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine if hypertonic saline with and without dextran can improve neurologic outcomes in victims of severe traumatic brain injury (TBI). Injury and lost blood from trauma can cause your body to go into shock (low blood pressure related to blood loss). This decreased blood flow can lead to organ damage. In order to restore the blood pressure and blood flow, the medics give fluids into the patients' veins as soon as possible. This is called "resuscitation". The fluid most commonly used is "isotonic" or one that is the same salt concentration as the blood. The investigators are trying to determine if infusing a "hypertonic" fluid or one more concentrated than the blood can increase the blood pressure and restore blood flow more efficiently. The hypertonic fluids they are using are called hypertonic saline with dextran (HSD) and hypertonic saline (no dextran). Hypertonic saline is a salt solution that is slightly more concentrated than blood. Dextran is a sugar solution.
Detailed Description
To determine if prehospital administration of 7.5% Hypertonic Saline in 6% Dextran-70 (HSD) OR 7.5% Hypertonic Saline (HS) compared to current standard therapy with NS as an initial resuscitation fluid affects neurological outcome following severe traumatic brain injury. Trauma is the leading cause of death among North Americans between the ages of 1 and 44 years. The majority of these deaths result from hypovolemic shock or severe brain injury. Patients in hypovolemic shock develop a state of systemic tissue ischemia then a subsequent reperfusion injury at the time of fluid resuscitation. Conventional resuscitation involves the IV administration of a large volume of isotonic or slightly hypotonic (lactated ringers, LR) solutions beginning in the pre-hospital setting. Although not conclusive, prior studies have suggested that alternative resuscitation with hypertonic saline (7.5%) solutions may reduce morbidity or mortality in these patients. Furthermore, hypertonic fluids may have specific advantages in the brain-injured patient, as they may aid in the rapid restoration of cerebral perfusion and prevent extravascular fluid sequestration, thereby limiting secondary brain injury. In addition, recent studies have demonstrated that hypertonicity significantly alters the activation of inflammatory cells, an effect that may reduce subsequent organ injury from ischemia-reperfusion and decrease nosocomial infection. This study is a randomized, double-blind, three-arm placebo controlled trial designed to evaluate the clinical outcome of trauma patients with severe TBI as manifested by a pre-hospital GCS of 8 or less. Patients will be randomized to a single 250cc IV dose of 7.5% saline in 6% Dextran-70 (HSD), 7.5% saline (HS) or normal saline as the initial fluid for pre-hospital resuscitation. No additional interventions will occur once the patient is admitted to the hospital. In hospital data collection will last up to 28 days. Patients will have neurologic outcome measurements at discharge, 1 month post discharge, and 6 months post injury. Enrollment will be restricted to age ≥ 15 years or ≥ 50 kg if age is unknown.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Brain Injuries, Traumatic
Keywords
Traumatic, Brain injury

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
1331 (Actual)

8. Arms, Groups, and Interventions

Arm Title
7.5% hypertonic saline/6% dextran (HSD)
Arm Type
Experimental
Arm Description
250 ml intravenous bolus administration of 7.5% saline/6% dextran 70
Arm Title
7.5% hypertonic saline (HS)
Arm Type
Experimental
Arm Description
250 ml intravenous bolus administration of 7.5% hypertonic saline
Arm Title
0.9% normal saline (NS)
Arm Type
Placebo Comparator
Arm Description
250 ml intravenous bolus administration of 0.9% saline
Intervention Type
Drug
Intervention Name(s)
7.5% Hypertonic Saline in 6% Dextran-70 (HSD)
Other Intervention Name(s)
RescueFlo
Intervention Description
250 ml intravenous bolus administration of 7.5% saline/6% dextran 70 administered as a one-time bolus fluid for initial resuscitation to injured patients with suspected severe traumatic brain injury in the out-of-hospital setting.
Intervention Type
Drug
Intervention Name(s)
7.5% Hypertonic Saline (HS)
Intervention Description
250 ml intravenous bolus administration of 7.5% hypertonic saline administered as a one-time bolus fluid for initial resuscitation to injured patients with suspected severe traumatic brain injury in the out-of-hospital setting.
Intervention Type
Drug
Intervention Name(s)
0.9% Normal Saline (NS)
Intervention Description
250 ml intravenous bolus administration of 0.9% saline administered as a one-time bolus fluid for initial resuscitation to injured patients with suspected severe traumatic brain injury in the out-of-hospital setting.
Primary Outcome Measure Information:
Title
Glasgow Outcome Scale-Extended (GOSE)≤4 at 6 Months: Completer Analysis
Description
Glasgow outcome score extended (GOSE) contains eight categories: 1. Dead, 2. Vegetative State (VS), 3. Lower Severe Disability (Lower SD), 4. Upper Severe Disability (Upper SD), 5. Lower Moderate Disability (Lower MD), 6. Upper Moderate Disability (Upper MD), 7. Lower Good Recovery (Lower GR) and 8. Upper Good Recovery (Upper GR). A measured neurological outcome of GOSE≤4 is a poor outcome of severe disability, vegetative state, or death. Completer analysis includes only those patients with GOSE completed at 6 months after injury.
Time Frame
6 months after injury
Title
Glasgow Outcome Scale-Extended (GOSE)≤4 at 6 Months: Imputed Analysis
Description
Glasgow outcome score extended (GOSE) contains 8 categories: 1. Dead, 2. Vegetative State, 3. Lower Severe Disability, 4. Upper Severe Disability, 5. Lower Moderate Disability, 6. Upper Moderate Disability, 7. Lower Good Recovery and 8. Upper Good Recovery. To adjust for 15% of subjects with absent 6-month GOSE data, an analysis using 20 hot deck imputations for the 6-month GOSE was done using data from patients who were discharged alive based on 1-month post discharge GOSE data or discharge GOSE (if 1-month post discharge data were not available), length of hospital stay, and treatment group.
Time Frame
6 months after injury
Secondary Outcome Measure Information:
Title
Subgroup of Participants With Head Abbreviated Injury Scores (AIS) Greater Than or Equal to 4 (Head AIS≥4) Assessed to Have Glasgow Outcome Scale-Extended (GOSE)≤4 at 6 Months: Imputed Analysis
Description
The Abbreviated Injury Scale (AIS) ranks injuries on a scale of 1 to 6, with 1 being minor, 2 moderate, 3 serious, 4 severe, 5 critical and 6 an unsurvivable injury. A priori secondary analyses included the subgroup of participants in each intervention group with a head AIS≥4, which is a diagnostic indicator of severe to lethal head injury. Of this subset of participants with AIS≥4, a second subset of participants with a GOSE≤4 at the 6 month follow up was analyzed. GOSE≤4 represents Upper Severe Disability or worse outcomes. 15% of subjects required imputation analysis for 6-month GOSE.
Time Frame
6 months after injury
Title
Subgroup of Participants With Head Abbreviated Injury Scores (AIS) Greater Than or Equal to 2 (Head AIS≥2) Assessed to Have Glasgow Outcome Scale-Extended (GOSE)≤4 at 6 Months: Imputed Analysis
Description
The Abbreviated Injury Scale (AIS) ranks injuries on a scale of 1 to 6, with 1 being minor, 2 moderate, 3 serious, 4 severe, 5 critical and 6 an unsurvivable injury. A priori secondary analyses included the subgroup of participants in each intervention group with a head AIS≥2, which is a diagnostic indicator of moderate to lethal head injury. Of this subset of participants with AIS≥2, a second subset of participants with a GOSE≤4 at the 6 month follow up was analyzed. GOSE≤4 represents Upper Severe Disability or worse outcomes. 15% of subjects required imputation analysis for 6-month GOSE.
Time Frame
6 months after injury
Title
Disability Rating Score (DRS) Categories of Disability
Description
The DRS is an additional measure of neurological outcome that categorizes the patient's level of disability on a scale of 0 to 29, with 0 indicating no disability to 29 indicating extreme vegetative state. To adjust for 15% of subjects with absent 6-month DRS data, an analysis using 20 hot deck imputations for the 6-month DRS was done using data from patients who were discharged alive based on 1-month post discharge DRS data or discharge DRS (if 1-month post discharge data were not available), length of hospital stay, and treatment group.
Time Frame
6 months after injury
Title
28 Day Survival
Description
The patient who is admitted to the hospital after injury and is alive on the 28th day after injury. For 28-day survival, patients with missing 28-day vital status who were known to be discharged alive prior to 28 days were assumed to be alive at day 28.
Time Frame
28 days after injury
Title
Survival at Hospital Discharge up to 6 Months From Date of Injury
Description
The patient who is admitted to the hospital alive after injury and is alive when discharged from the hospital up to 6 months from the date of injury.
Time Frame
Date of hospital discharge up to 6 months from date of injury
Title
Acute Respiratory Distress Syndrome (ARDS)-Free Survival to Day 28
Description
The patient is alive and free of ARDS from the date of injury through to the 28th day following injury. The diagnosis of ARDS is based on standard criteria: a) hypoxia with a ratio of arterial oxygen pressure to percent oxygen delivered of less than 200; b) bilateral infiltrates on chest X-ray; and c) clinical evidence of increased left atrial pressure or pulmonary artery wedge pressure of greater than 18 mmHg.
Time Frame
From day of injury to 28 days after injury
Title
Worst Multiple Organ Dysfunction Score (MODS) Through Day 28
Description
Multiple Organ Dysfunction Score is described as: Six organ systems were chosen: 1) respiratory; 2) renal; 3) hepatic; 4) cardiovascular; 5) hematologic; and 6) neurologica. A score of 0-4 was allotted for each organ according to function (0 being normal function through 4 for most severe dysfunction) with a maximum score of 24. The worst score based on available data (missing values were assumed normal) was taken for calculation of the aggregate score. Deaths are assigned the worst score (24).
Time Frame
From day of injury to 28 days after injury
Title
Ventilator-free Days Through Day 28
Description
The number of days beginning with the day of 911 call counted as "Day 0" through day 28 that the patient did not require mechanical ventilation. Deaths are assigned the worst score (0).
Time Frame
From day of injury to 28 days after injury
Title
Days Alive Out of the Intensive Care Unit (ICU) Through Day 28
Description
The number of days the patient is alive and not being cared for in the intensive care unit
Time Frame
From day of injury to 28 days after injury
Title
Days Alive Out of the Hospital Through Day 28
Description
The number of days the patient is alive and no longer an inpatient in the hospital through day 28
Time Frame
From day of injury to 28 days after injury
Title
Presence of Nosocomial Infections
Description
Includes one or more nosocomial infections diagnosed during the hospital stay but not present on admission to the hospital from the following list: pneumonia, bloodstream infection, urinary tract infection, and/or wound infection
Time Frame
From day of injury to 28 days after injury
Title
Total Fluids in First 24 Hours
Description
The average (mean) total amount of intravenous (IV) fluids given in the pre-hospital setting and the hospital setting in the first 24 hours following the time of the 911 call
Time Frame
First 24 hours from the time dispatch received 911 call
Title
Packed Red Blood Cells (PRBC) First 24 Hours
Description
The average (mean) number of units of packed red blood cells (PRBC) transfused in the first 24 hours following the time of the 911 call in each group.
Time Frame
First 24 hours from the time dispatch received 911 call
Title
Discharge Disposition
Description
Disposition of patient at the time of discharge from the acute care hospital
Time Frame
Duration of hospital stay

10. Eligibility

Sex
All
Minimum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Blunt trauma Pre-hospital Glasgow Coma Scale equal to or less than 8(GCS≤8)* Age 15 years or older or 50 kg or more Patients who met the inclusion criteria above and did not meet the exclusion criteria below but who had systolic blood pressure (SBP) ≤70 or SBP>70 and SBP≤90 and heart rate (HR)≥108 were included in the Hypertonic Resuscitation following Traumatic Injury study that focused on shock patients who may or may not have a traumatic brain injury (TBI). In other words, patients with both TBI and shock would not be included in this study of TBI patients without shock at the time of enrollment. Exclusion Criteria: Known or suspected pregnancy Age younger than 15 years or less than 50 kg if age unknown Ongoing pre-hospital cardiopulmonary resuscitation (CPR) Administration of more than 2L crystalloid or any colloid or blood products Severe hypothermia (T less than 28C) Drowning or asphyxia due to hanging Burns TBSA more than 20% Isolated penetrating injury to the head Inability to obtain pre-hospital intravenous access Time of call received at dispatch to study intervention more than four hours Known prisoners
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Myron L Weisfeldt, MD
Organizational Affiliation
Resuscitation Outcomes Consortium
Official's Role
Study Chair
Facility Information:
Facility Name
Alabama Resuscitation Center, University of Alabama
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35249
Country
United States
Facility Name
Orange County/UC Irvine
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States
Facility Name
UCSD-San Diego Resuscitation Research Center
City
San Diego
State/Province
California
ZIP/Postal Code
92103
Country
United States
Facility Name
Iowa Resuscitation Network, University of Iowa Carver College of Medicine
City
Iowa City
State/Province
Iowa
ZIP/Postal Code
52242
Country
United States
Facility Name
Portland Resuscitation Outcomes Consortium, Oregon Health & Sciences University
City
Portland
State/Province
Oregon
ZIP/Postal Code
97239
Country
United States
Facility Name
The Pittsburgh Resuscitation Network, University of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Facility Name
The Regional Medical Center at Memphis
City
Memphis
State/Province
Tennessee
ZIP/Postal Code
38103
Country
United States
Facility Name
Dallas Center for Resuscitation Research, University of Texas Southwestern Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390
Country
United States
Facility Name
Seattle-King County Center for Resuscitation Research, University of Washington
City
Seattle
State/Province
Washington
ZIP/Postal Code
98195
Country
United States
Facility Name
Milwaukee Resuscitation Network, Medical College of Wisconsin
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53226
Country
United States
Facility Name
University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1Y4E9
Country
Canada
Facility Name
Toronto Regional Resuscitation Research Out-of-Hospital Network, University of Toronto
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5B1W8
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
20924011
Citation
Bulger EM, May S, Brasel KJ, Schreiber M, Kerby JD, Tisherman SA, Newgard C, Slutsky A, Coimbra R, Emerson S, Minei JP, Bardarson B, Kudenchuk P, Baker A, Christenson J, Idris A, Davis D, Fabian TC, Aufderheide TP, Callaway C, Williams C, Banek J, Vaillancourt C, van Heest R, Sopko G, Hata JS, Hoyt DB; ROC Investigators. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA. 2010 Oct 6;304(13):1455-64. doi: 10.1001/jama.2010.1405.
Results Reference
result
PubMed Identifier
25072443
Citation
Tisherman SA, Schmicker RH, Brasel KJ, Bulger EM, Kerby JD, Minei JP, Powell JL, Reiff DA, Rizoli SB, Schreiber MA. Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the Resuscitation Outcomes Consortium. Ann Surg. 2015 Mar;261(3):586-90. doi: 10.1097/SLA.0000000000000837.
Results Reference
derived

Learn more about this trial

Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)

We'll reach out to this number within 24 hrs